The test for association was run based on the phenotype (CD, UC or IBD) indicated by the common variant association in the region13 (that is, truncating variants in a gene associated only to CD such as at NOD2 would be tested for CD versus control association). This evidence concerns the gene NOD2 and inflammatory bowel disease.